ARFGEF1
Brefeldin A-inhibited guanine nucleotide-exchange protein 1
Also known as: ARFGEP1, BIG1, BIG1_HUMAN, DKFZP434L057, p200
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y6D6
- Gene
- ARFGEF1
- Ensembl
- ENSG00000066777
- Chromosome
- 8
- Canonical length
- 1849 aa
- Protein class
- Disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
ADP-ribosylation factors (ARFs) play an important role in intracellular vesicular trafficking. The protein encoded by this gene is involved in the activation of ARFs by accelerating replacement of bound GDP with GTP. It contains a Sec7 domain, which may be responsible for guanine-nucleotide exchange activity and also brefeldin A inhibition. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
1849 residues, UniProt reviewed canonical sequence.
>Q9Y6D6|ARFGEF1
1 MYEGKKTKNM FLTRALEKIL ADKEVKKAHH SQLRKACEVA LEEIKAETEK QSPPHGEAKA
61 GSSTLPPVKS KTNFIEADKY FLPFELACQS KCPRIVSTSL DCLQKLIAYG HLTGNAPDST
121 TPGKKLIDRI IETICGCFQG PQTDEGVQLQ IIKALLTAVT SQHIEIHEGT VLQAVRTCYN
181 IYLASKNLIN QTTAKATLTQ MLNVIFARME NQALQEAKQM EKERHRQHHH LLQSPVSHHE
241 PESPQLRYLP PQTVDHISQE HEGDLDLHTN DVDKSLQDDT EPENGSDISS AENEQTEADQ
301 ATAAETLSKN EVLYDGENHD CEEKPQDIVQ NIVEEMVNIV VGDMGEGTTI NASADGNIGT
361 IEDGSDSENI QANGIPGTPI SVAYTPSLPD DRLSVSSNDT QESGNSSGPS PGAKFSHILQ
421 KDAFLVFRSL CKLSMKPLSD GPPDPKSHEL RSKILSLQLL LSILQNAGPI FRTNEMFINA
481 IKQYLCVALS KNGVSSVPEV FELSLSIFLT LLSNFKTHLK MQIEVFFKEI FLYILETSTS
541 SFDHKWMVIQ TLTRICADAQ SVVDIYVNYD CDLNAANIFE RLVNDLSKIA QGRGSQELGM
601 SNVQELSLRK KGLECLVSIL KCMVEWSKDQ YVNPNSQTTL GQEKPSEQEM SEIKHPETIN
661 RYGSLNSLES TSSSGIGSYS TQMSGTDNPE QFEVLKQQKE IIEQGIDLFN KKPKRGIQYL
721 QEQGMLGTTP EDIAQFLHQE ERLDSTQVGE FLGDNDKFNK EVMYAYVDQH DFSGKDFVSA
781 LRMFLEGFRL PGEAQKIDRL MEKFAARYLE CNQGQTLFAS ADTAYVLAYS IIMLTTDLHS
841 PQVKNKMTKE QYIKMNRGIN DSKDLPEEYL SAIYNEIAGK KISMKETKEL TIPTKSSKQN
901 VASEKQRRLL YNLEMEQMAK TAKALMEAVS HVQAPFTSAT HLEHVRPMFK LAWTPFLAAF
961 SVGLQDCDDT EVASLCLEGI RCAIRIACIF SIQLERDAYV QALARFTLLT VSSGITEMKQ
1021 KNIDTIKTLI TVAHTDGNYL GNSWHEILKC ISQLELAQLI GTGVKPRYIS GTVRGREGSL
1081 TGTKDQAPDE FVGLGLVGGN VDWKQIASIQ ESIGETSSQS VVVAVDRIFT GSTRLDGNAI
1141 VDFVRWLCAV SMDELLSTTH PRMFSLQKIV EISYYNMGRI RLQWSRIWEV IGDHFNKVGC
1201 NPNEDVAIFA VDSLRQLSMK FLEKGELANF RFQKDFLRPF EHIMKRNRSP TIRDMVVRCI
1261 AQMVNSQAAN IRSGWKNIFS VFHLAASDQD ESIVELAFQT TGHIVTLVFE KHFPATIDSF
1321 QDAVKCLSEF ACNAAFPDTS MEAIRLIRHC AKYVSDRPQA FKEYTSDDMN VAPEDRVWVR
1381 GWFPILFELS CIINRCKLDV RTRGLTVMFE IMKTYGHTYE KHWWQDLFRI VFRIFDNMKL
1441 PEQQTEKAEW MTTTCNHALY AICDVFTQYL EVLSDVLLDD IFAQLYWCVQ QDNEQLARSG
1501 TNCLENVVIL NGEKFTLEIW DKTCNCTLDI FKTTIPHALL TWRPNSGETA PPPPSPVSEK
1561 PLDTISQKSV DIHDSIQPRS VDNRPQAPLV SASAVNEEVS KIKSTAKFPE QKLFAALLIK
1621 CVVQLELIQT IDNIVFFPAT SKKEDAENLA AAQRDAVDFD VRVDTQDQGM YRFLTSQQLF
1681 KLLDCLLESH RFAKAFNSNN EQRTALWKAG FKGKSKPNLL KQETSSLACG LRILFRMYMD
1741 ESRVSAWEEV QQRLLNVCSE ALSYFLTLTS ESHREAWTNL LLLFLTKVLK ISDNRFKAHA
1801 SFYYPLLCEI MQFDLIPELR AVLRRFFLRI GVVFQISQPP EQELGINKQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARFGEF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- retina: 34 nTPM
- testis: 27 nTPM
- parathyroid gland: 26 nTPM
- bone marrow: 26 nTPM
- kidney: 21 nTPM
- thyroid gland: 21 nTPM
Single-cell type
- neutrophil progenitors: 1,701 nCPM
- neutrophils: 688 nCPM
- cone photoreceptor cells: 528 nCPM
- rod photoreceptor cells: 481 nCPM
- renal connecting tubule cells: 395 nCPM
- sertoli cells: 392 nCPM
Immune cell
- basophil: 6.2 nTPM
- neutrophil: 5.1 nTPM
- eosinophil: 4.3 nTPM
- T-reg: 3.9 nTPM
- MAIT T-cell: 3.6 nTPM
- naive CD4 T-cell: 3 nTPM
Brain region
- choroid plexus: 49 nTPM
- cerebellum: 44 nTPM
- midbrain: 42 nTPM
- medulla oblongata: 41 nTPM
- thalamus: 41 nTPM
- pons: 41 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ARFGEF1.
Disease | AllUniProt
Conditions ARFGEF1 is implicated in, by any mechanism.
- Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures (DEDISB) MIM:619964
Disease | GeneticClinVar
67 pathogenic / likely-pathogenic of 483 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Developmental delay, impaired speech, and behavioral abnormalities, with or without seizures
- Global developmental delay
- Intellectual disability
- Delayed speech and language development
- Atypical behavior
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.14
- gnomAD pLI
- 1
- gnomAD missense Z
- 5.37
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 13% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endomembrane system organization
- exocytosis
- glycoprotein biosynthetic process
- Golgi organization
- negative regulation of actin filament polymerization
- negative regulation of GTPase activity
- neuron projection development
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of wound healing
- protein transport
- regulation of ARF protein signal transduction
- regulation of establishment of cell polarity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sec7 domain
- Armadillo-like helical
- Mon2/Sec7/BIG1-like, HDS
- Armadillo-type fold
- Sec7, C-terminal domain superfamily
- Mon2/Sec7/BIG1-like, dimerisation and cyclophilin-binding domain
- Mon2/Sec7/BIG1-like, HUS domain
- Sec7 domain superfamily
- Sec7/BIG1-like, C-terminal domain
- Sec7 domain
- Mon2/Sec7/BIG1-like, HDS
- Mon2/Sec7/BIG1-like, HUS domain
- Mon2/Sec7/BIG1-like, dimerisation and cyclophilin-binding domain
- BIG2 C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARFGEF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARFGEF1 as an antibody target. Whether an autoantibody or antibody against ARFGEF1 could matter depends on whether native ARFGEF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARFGEF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARFGEF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...